Colgate-Palmolive (India) Ltd Valuation Shifts Signal Heightened Price Risk

Valuation Metrics Reflect Elevated Price Levels

As of 17 September 2026, Colgate-Palmolive (India) Ltd trades at a P/E ratio of 37.04, a level that places it firmly in the "very expensive" category according to MarketsMOJO’s grading system. This is a notable increase from its previous valuation grade of "expensive," signalling that investors are paying a premium for the company’s earnings compared to historical norms. The price-to-book value ratio stands at an eye-watering 32.00, underscoring the market’s high expectations for the company’s asset utilisation and growth prospects.

Other valuation multiples also highlight the stretched pricing. The enterprise value to EBIT (EV/EBIT) ratio is 28.12, while the EV to EBITDA ratio is 25.93, both indicating that the stock is trading at a significant premium relative to its earnings before interest, taxes, depreciation, and amortisation. The EV to capital employed ratio is exceptionally high at 302.87, reflecting the market’s willingness to pay a substantial premium for the company’s capital base. Meanwhile, the EV to sales ratio of 7.94 further confirms the expensive nature of the stock.

Comparative Analysis with FMCG Peers

When compared with key FMCG peers, Colgate-Palmolive’s valuation remains elevated but not the highest in the sector. Marico, for instance, trades at a P/E of 55.93 and EV/EBITDA of 41.61, both significantly higher than Colgate’s multiples, while FSN E-Commerce’s P/E ratio is an extraordinary 350.23. Dabur India, by contrast, is rated as "fair" with a P/E of 34.25 and EV/EBITDA of 25.37, slightly below Colgate’s levels. Patanjali Foods, also "very expensive," trades at a P/E of 18.31, which is considerably lower than Colgate’s, suggesting a more moderate premium. Procter & Gamble Hygiene is rated "fair" with a P/E of 31.34 and EV/EBITDA of 22.53.

This peer comparison highlights that while Colgate-Palmolive is expensive, it is not an outlier in the FMCG space, where premium valuations are common for companies with strong brand equity and consistent earnings growth.

Financial Performance and Returns Contextualise Valuation

Colgate-Palmolive’s return on capital employed (ROCE) and return on equity (ROE) metrics are exceptionally strong, with the latest ROCE at 1059.37% and ROE at 86.41%. These figures reflect the company’s highly efficient use of capital and strong profitability, which partly justify the premium valuation. The dividend yield stands at a modest 2.58%, indicating a moderate income return for investors relative to the stock price.

However, the stock’s recent price performance has been mixed. Over the past week, the share price rose by 3.28%, outperforming the Sensex which declined by 0.57%. Yet, over longer periods, the stock has underperformed the benchmark index. Year-to-date, Colgate-Palmolive’s stock has declined by 10.20%, compared to the Sensex’s 12.77% fall, showing relative resilience. Over one year, the stock has dropped 20.84%, significantly lagging the Sensex’s 9.76% gain. The three-year return is negative at -5.85%, while the Sensex gained 9.58% over the same period. Over five and ten years, the stock has delivered positive returns of 8.60% and 92.62% respectively, though these lag the Sensex’s 25.69% and 159.93% gains.

Valuation Grade Downgrade Reflects Heightened Caution

MarketsMOJO has downgraded Colgate-Palmolive’s mojo grade from "Strong Sell" to "Sell" as of 17 April 2026, reflecting the shift in valuation from expensive to very expensive. The current mojo score of 37.0 underscores the cautious stance investors should adopt given the stretched multiples and the stock’s recent underperformance relative to the broader market. This downgrade signals that while the company’s fundamentals remain robust, the price paid for these fundamentals is less attractive than before.

Investors should weigh the company’s strong profitability and brand strength against the risk of valuation contraction, especially if earnings growth fails to meet elevated market expectations. The zero PEG ratio indicates that the price-to-earnings growth metric is not favourable, suggesting that the stock’s price growth is not adequately supported by earnings growth forecasts.

Price Action and Trading Range

On 17 September 2026, Colgate-Palmolive’s stock closed at ₹1,864.00, up 2.14% from the previous close of ₹1,825.00. The intraday high reached ₹1,899.00, while the low was ₹1,825.35. The stock remains below its 52-week high of ₹2,378.00 but comfortably above its 52-week low of ₹1,781.60, indicating a relatively stable trading range despite valuation concerns.

Given the mid-cap market capitalisation grade, the stock attracts a specific investor segment focused on growth potential balanced with moderate liquidity. However, the very expensive valuation metrics may deter value-oriented investors seeking more attractive entry points.

Conclusion: Valuation Premium Warrants Caution

Colgate-Palmolive (India) Ltd’s transition from expensive to very expensive valuation territory highlights the challenges investors face in balancing the company’s strong fundamentals against its stretched price multiples. While the firm’s exceptional ROCE and ROE metrics justify a premium to some extent, the elevated P/E and P/BV ratios suggest limited margin for error in earnings growth.

Relative to its FMCG peers, Colgate-Palmolive remains expensive but not the most overvalued, indicating that the sector as a whole commands premium valuations. The downgrade in mojo grade to "Sell" reflects increased caution warranted by the current price levels. Investors should carefully monitor earnings updates and sector dynamics before committing fresh capital, as valuation contraction could weigh on returns if growth disappoints.

In summary, while Colgate-Palmolive’s brand strength and profitability remain intact, the shift in valuation parameters signals a less attractive price entry point, urging investors to consider alternative FMCG stocks with more favourable risk-reward profiles.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →